Caption Management’s bluebird bio BLUE Stock Holding History

Caption Management’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-500	Closed	-$30.4K	–	1350
2023 Q3	$30.4K	Hold	500	–	–	﹤0.01%	1208
2023 Q2	$32.9K	Buy	+500	New	+$36.6K	﹤0.01%	1022
2021 Q3	–	Sell	-2,734	Closed	-$1.13M	–	1516
2021 Q2	$1.13M	Sell	2,734 -2,852	-51%	-$1.13M	0.01%	856
2021 Q1	$2.18M	Buy	5,586 +4,351	+352%	+$2.14M	0.05%	493
2020 Q4	$692K	Buy	+1,235	New	+$783K	0.02%	679
2020 Q3	–	Sell	-193	Closed	-$151K	–	1036
2020 Q2	$152K	Sell	193 -8	-4%	-$6.03K	0.01%	815
2020 Q1	$119K	Sell	201 -1,806	-90%	-$1.76M	0.01%	754
2019 Q4	$2.28M	Buy	2,007 +509	+34%	+$553K	0.08%	330
2019 Q3	$1.78M	Buy	1,498 +1,035	+224%	+$1.58M	0.09%	263
2019 Q2	$763K	Buy	+463	New	+$801K	0.04%	414
2019 Q1	–	Sell	-270	Closed	-$475K	–	574
2018 Q4	$347K	Sell	270 -232	-46%	-$356K	0.03%	372
2018 Q3	$950K	Buy	502 +155	+45%	+$320K	0.05%	349
2018 Q2	$706K	Buy	+347	New	+$791K	0.05%	290

Other funds holding BLUE

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

GCM

Ghisallo Capital Management Boston, Massachusetts $3.63B AUM 30.51% 1-Year Est. Return

Caption Management's BLUE Position: Q4 2023 in Review

Caption Management sold out of bluebird bio (BLUE) in Q4 2023, closing a stake of 500 shares — an estimated $30.4K sold.

Caption Management first reported a position in BLUE in Q2 2018 and held it in 13 quarters. The position peaked at $2.28M in Q4 2019. 187 funds tracked by Wall St. Rank hold BLUE as of Q4 2023.

Caption Management reported no remaining bluebird bio position as of Q4 2023 after selling out during the quarter.
Caption Management sold 500 bluebird bio shares in Q4 2023, an estimated $30.4K.
Caption Management first reported a position in bluebird bio in Q2 2018 and held it in 13 quarters.
Caption Management's bluebird bio position peaked at $2.28M in Q4 2019.
187 funds tracked by Wall St. Rank held bluebird bio as of Q4 2023.

Based on Caption Management's 13F filing for Q4 2023, filed 14 Feb 2024.